v3.25.4

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) | 3 Months Ended
--- | ---
Dec. 31, 2025
Accounting Policies [Abstract] |
Schedule of Summarizes the Composition of the Company Accrued Liabilities | The following table summarizes the composition of the Company’s accrued liabilities on the Condensed Consolidated Balance Sheets indicated:
($ in thousands) |  | December 31, 2025 |  |  | September 30, 2025 |
Indirect tax contingencies |  | $ | 64,772 |  |  | $ | 64,481 |
Accrued operating expenses |  |  | 24,433 |  |  |  | 30,562 |
Accrued payroll expenses |  |  | 8,103 |  |  |  | 15,530 |
Indirect tax accruals |  |  | 872 |  |  |  | 6,017 |
Other accrued liabilities |  |  | 5,509 |  |  |  | 954 |
Accrued liabilities |  | $ | 103,689 |  |  | $ | 117,544 |
Schedule of Earnings Per Share Basic and Diluted | Provided below is the (Loss) income per share calculation for the three months ended December 31, 2025 and 2024:
|  | For the three months ended December 31, |
($ in thousands, except share and per share amounts) |  | 2025 |  |  | 2024 |
Numerator |  |  |  |  |  |
Net (loss) income attributable to common shareholders - Basic |  | $ | (378,711 | ) |  | $ | 241,650 |
Non-cash interest expense on convertible notes |  |  | — |  |  |  | 119 |
Net (loss) income attributable to common shareholders - Dilutive |  |  | (378,711 | ) |  |  | 241,769 |
Denominator |  |  |  |  |  |
Weighted-average common shares outstanding - Basic |  |  | 281,474,949 |  |  |  | 284,549,900 |
Dilutive impact of stock options and other share-based awards |  |  | — |  |  |  | 652,120 |
Dilutive impact of convertible notes |  |  | — |  |  |  | 6,685,121 |
Weighted-average common shares outstanding - Dilutive |  |  | 281,474,949 |  |  |  | 291,887,141 |
(Loss) income per common share attributable to common shareholders |  |  |  |  |  |
Basic |  | $ | (1.35 | ) |  | $ | 0.85 |
Diluted |  | $ | (1.35 | ) |  | $ | 0.83 |
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share | The number of shares excluded from diluted earnings per share for the three months ended December 31, 2025 and 2024 are noted in the table below. Such shares were excluded as their assumed conversion would have been antidilutive or, for preferred stock, because the change-in-control conversion contingency was not satisfied.
|  | For the three months ended December 31, |
|  | 2025 |  |  | 2024 |
Convertible notes |  |  | 103,941,450 |  |  |  | — |
Series A preferred stock conversion |  |  | 5,250,000 |  |  |  | 5,250,000 |
Anti-dilutive warrants |  |  | 1,604,559 |  |  |  | 1,586,999 |
Anti-dilutive stock options |  |  | 2,062,489 |  |  |  | 1,676,431 |
Anti-dilutive restricted stock awards |  |  | 13,634,730 |  |  |  | — |
Total anti-dilutive securities |  |  | 126,493,228 |  |  |  | 8,513,430 |
Schedule of Financial Instruments | The following table presents the Company’s assets and liabilities that are measured and recorded at fair value on the Company’s Condensed Consolidated Balance Sheets on a recurring basis and their level within the fair value hierarchy as of December 31, 2025 and September 30, 2025:
December 31, 2025 |  |  |  |  |  |  |  |  |  |  |  |
($ in thousands) |  | Amount |  |  | Level 1 |  |  | Level 2 |  |  | Level 3 |
Assets: |  |  |  |  |  |  |  |  |  |  |  |
Cash equivalents(1) |  | $ | 27,154 |  |  | $ | 27,154 |  |  | $ | — |  |  | $ | — |
Receivable from bitcoin collateral(2) |  |  | 144,163 |  |  |  | — |  |  |  | 144,163 |  |  |  | — |
Bitcoin |  |  | 1,001,997 |  |  |  | 1,001,997 |  |  |  | — |  |  |  | — |
Liabilities: |  |  |  |  |  |  |  |  |  |  |  |
DAM derivative liabilities |  |  | 663 |  |  |  | — |  |  |  | — |  |  |  | 663 |
Interest rate swap derivative |  |  | 86 |  |  |  | — |  |  |  | 86 |  |  |  | — |
Warrant liabilities |  |  | 16 |  |  |  | — |  |  |  | 16 |  |  |  | — |
September 30, 2025 |  |  |  |  |  |  |  |  |  |  |  |
($ in thousands) |  | Amount |  |  | Level 1 |  |  | Level 2 |  |  | Level 3 |
Assets: |  |  |  |  |  |  |  |  |  |  |  |
Cash equivalents(1) |  | $ | 32,992 |  |  | $ | 32,992 |  |  | $ | — |  |  | $ | — |
Receivable from bitcoin collateral(2) |  |  | 294,648 |  |  |  | — |  |  |  | 294,648 |  |  |  | — |
Bitcoin |  |  | 1,189,443 |  |  |  | 1,189,443 |  |  |  | — |  |  |  | — |
Bitcoin derivative - Bitmain contracts |  |  | 233 |  |  |  | — |  |  |  | — |  |  |  | 233 |
Liabilities: |  |  |  |  |  |  |  |  |  |  |  |
Interest rate swap derivative |  |  | 93 |  |  |  | — |  |  |  | 93 |  |  |  | — |
Warrant liabilities |  |  | 115 |  |  |  | — |  |  |  | 115 |  |  |  | — |
(1) Represents money market funds. (2) See Note 4 - Bitcoin for more information.

X
- References No definition available. + Details
Name: | us-gaap_AccountingPoliciesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of liabilities measured at fair value measured on a recurring or nonrecurring basis. Includes, but is not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 + Details
Name: | us-gaap_FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the components of accrued liabilities. + References No definition available. + Details
Name: | us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration